We developed a nephelometric procedure for determining concentrations of human plasma apolipoprotein (apo) A-IV. Results obtained correlate well with those measured by an established electroimmunodiffusion assay (r = 0.98; n = 56). Intra-and interassay CV5 were 2.4% and 2.0%, respectively, indicating excellent precision and reproducibility. Various conditions of sample treatment, such as adequate storage, freezing, and thawing, did not affect results significantly. However, keeping samples at 
and ELISA techniques (31) (32) (33) .
We have now developed a nephelometric method for ape A-N quantification, easily applicable to clinical laboratories in a fully automated format that allows high sample throughput while avoiding the use of radioactive tracer material.
Materials and Methods

Subjects
Blood samples were obtained from healthy subjects, mainly blood donors at the University of Marburg transfusion center and from the outpatient facility of the University Hospital at Marburg. Plasma was also obtained from patients seen at the outpatient facility, specifically those with renal disease and Crohn disease. The procedures were in accordance with the ethical standards of the University of Marburg responsible committee. All subjects were of Caucasian origin. Blood was drawn into tubes containing 0 or 1 g/L EDTA, and serum or plasma was obtained by low-speed centrifugation. Usually, we determined ape A-N concentrations in plasma. Plasmas with different ape A-N concentrations were pooled for determining the intraassay CV. In another set of experiments, plasmas were pooled to determine the interassay variance, and also to study interference from triglycerides.
Finally, we prepared six bigger pools (referred to as pools 1-6) of plasma to test calibration stability and storage conditions. 
Methods
Sample pretreatment.
Before measurement each sampie was pretreated with a clearing buffer, consisting of 100 U of cholesterol esterase, 3.55 g of L.aspartic acid magnesium salt, 0.60 g of Thesit, and 0.86 g of sodium cholate dissolved in 50 mL of 0.1 mol/L Tris, pH 7.7. We prepared the clearing buffer by mixing the reagents and dissolving them for 4 h at room temperature. 
Results
Assay Characterization
Calibration.
Six different dilutions of purified apo A-N were used as primary standard for calibration. Calibration curves generated from the purified ape A-N and the N/T secondary standard are illustrated in Fig. 1 .
Linearity.
Human plasma prediluted with 0.15 mol/L NaCl (up to 10-fold) was analyzed for ape A-N. The assay results varied linearly with ape A-N concentrations from 30 to 300 mg/L (y = -2.53 + x) (Fig. 2) .
Method comparison.
We assayed 56 samples simultaneously by nephelometry and by electroimmunodiffusion (28); results for the two assays correlated well (r = 0.98) (Fig. 3) . The values determined nephelometrically (y) tended to be somewhat lower than those obtained by electroimmunodiffusion (x): y = 0.32 + 1.lOx. Precision. To determine the intraassay CV, we mixed fresh sera with high, medium, and low concentrations of ape A-N to prepare three pools, then assayed in parallel 20 aliquots of each pool. Intraassay
CVs were 2.6%, 2.4%, and 2.0% for plasma pools with ape A-N concen- 
Interference from triglycerides.
Increasing amounts of chylomicrons and VLDL as the major triglyceride-car.
Sampleswere stored at 4C between the evaluations. n = 6 (days)each. 
Effect of various storage conditions.
Storage at -20#{176}C for 6 months as well as thawing and refreezing samples three times did not affect ape A-N concentrations. Sampies could also be kept at 4#{176}C for 7 days and as long as 4 h at 36#{176}C without significantly affecting ape A-N values. Ape A-N in samples stored at 20#{176}C for 4 days, however, increased slightly (Table 2) .
ClinicalValues
We investigated plasmas from apparently healthy adults, 40 men and 40 women (mean ± SD age 37 
Discussion
The application of ape A-N measurements to clinical questions has been hampered by the lack of a convenient assay. Here we report a simple nephelometric assay system that fulfills the criteria for broad clinical application with a high degree of precision. In addition measurements can be validly performed on fresh and frozen plasma samples, and no special preassay condi- To overcome the problem of unspecific sample turbidity, e.g., when lipemic samples are to be measured (37) (38) (39) (Ste 38 1/5-1) .
